Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SurModics, a provider of drug delivery and surface modification technologies to the healthcare industry, has reported total revenue of $17.97m for the third quarter ended 30 June 2011, as compared to $18.61m for the same period in 2010.
Subscribe to our email newsletter
SurModics‘ net income was $3.84m, compared to net loss of $916,000 for the same period in the prior year.
The company’s income from operations was $3.45m for the third quarter ended 30 June 2011, as compared to $2.22m for the same period in 2010.
For the nine months ended 30 June 2011 total revenue was $50.63m, compared to $54.35m for the same period in 2010.
Net income was $159,000 for the nine months ended 30 June 2011, as compared to $574,000 for the same period prior year.
For the nine months ended 30 June 2011, the company’s loss from operations was $132,000, as compared to $4.04m for the same period in 2010.